A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
about
Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review.Pembrolizumab use for the treatment of advanced melanoma.Bilateral uveitis and macular edema induced by Nivolumab: a case report.Combination nivolumab- and cabiralizumab-associated acute bilateral anterior and posterior scleritis and anterior uveitis.
P2860
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
@en
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
@nl
type
label
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
@en
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
@nl
prefLabel
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
@en
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
@nl
P2860
P356
P1433
P1476
A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma
@en
P2093
Kirollos S Hanna
P2860
P304
P356
10.1002/PHAR.1839
P407
P577
2016-10-26T00:00:00Z